High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe detude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Conclusion: Tumor uptake on 18F-FDOPA PET/CT is an independent prognostic factor in patients with metastatic midgut NETs.
Source: Journal of Nuclear Medicine - Category: Nuclear Medicine Authors: De Rycke, O., Perrier, M., Ouvrard, E., Mennetrey, C., Lachachi, C., Bando-Delaunay, A., Morland, D., Goichot, B., Taieb, D., Walter, T., Cadiot, G., Cros, J., Hentic, O., Ruszniewski, P., Lebtahi, R., Imperiale, A., de Mestier, L. Tags: Clinical Investigations Source Type: research
More News: Brain | Cancer & Oncology | Carcinoid Tumor | CT Scan | Liver | Men | Neurology | Nuclear Medicine | PET Scan | Study | Urology & Nephrology